Home Cart Sign in  
Chemical Structure| 1839150-63-8 Chemical Structure| 1839150-63-8

Structure of EB-3D
CAS No.: 1839150-63-8

Chemical Structure| 1839150-63-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

EB-3D is a novel potent and selective choline kinase ChoKα inhibitor with an IC50 of 1 μM. EB-3D induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells and induces senescence in breast cancer cell lines through the activation of the metabolic sensor AMPK and the subsequent dephosphorylation of mTORC1 downstream targets.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of EB-3D

CAS No. :1839150-63-8
Formula : C30H36Br2N4O2
M.W : 644.44
SMILES Code : CN(C1=CC=[N+](CC2=CC=C(OCCOC3=CC=C(C[N+]4=CC=C(N(C)C)C=C4)C=C3)C=C2)C=C1)C.[Br-].[Br-]
MDL No. :MFCD32689452
InChI Key :SCXVGPSPZQBBDM-UHFFFAOYSA-L
Pubchem ID :90467110

Safety of EB-3D

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF-7 1 μM 72 hours EB-3D induced cellular senescence via AMPK-mTOR pathway activation Cancers (Basel). 2018 Oct 22;10(10):391
MDA-MB-468 1.25 μM 24 hours EB-3D induced G1 phase cell cycle arrest and increased p21 expression Cancers (Basel). 2018 Oct 22;10(10):391
MDA-MB-231 1 μM 24-48 hours EB-3D significantly reduced phosphocholine (PCho) levels and inhibited cell proliferation Cancers (Basel). 2018 Oct 22;10(10):391
HepG2 cells 1 μM to 30 μM 24 hours To investigate the effects of EB-3D and EB-3P on phosphatidylcholine (PC) and sphingomyelin (SM) biosynthesis. Results showed that both inhibitors significantly inhibited choline incorporation into PC and SM with IC50 values of approximately 5 μM. Sci Rep. 2019 Mar 25;9(1):5109

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice E0771 mammary adenocarcinoma model Intraperitoneal injection 1 mg/kg Every other day for 4 weeks EB-3D significantly reduced tumor volume and metastatic nodules Cancers (Basel). 2018 Oct 22;10(10):391

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.55mL

0.31mL

0.16mL

7.76mL

1.55mL

0.78mL

15.52mL

3.10mL

1.55mL

References

 

Historical Records

Categories